The relationship of TFPI, Lp(a), and oxidized LDL antibody levels in patients with coronary artery disease

Clinical Biochemistry

Volumn 38, Issue 1, 2005, Pages 92-96

  Bilgen, Dilek ^a   Sönmez, Hüseyin ^a   Ekmekçi, Hakan ^a   Ulutin, Turgut ^a   Öztürk, Zeynep ^a   Kökoǧlu, Emine ^a   Bayram, Çiǧdem ^a   Soner, Ali ^a   Domaniç, Nergiz ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

CAD; Lp(a); oLAB; TFPI

Indexed keywords

BIOLOGICAL MARKER; HIGH DENSITY LIPOPROTEIN; LIPOPROTEIN A; OXIDIZED LOW DENSITY LIPOPROTEIN; THIOBARBITURIC ACID DERIVATIVE; TISSUE FACTOR PATHWAY INHIBITOR; TISSUE FACTOR PATHWAY INHIBITOR 1; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD SAMPLING; CARDIOLOGY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INTERMETHOD COMPARISON; LIPID OXIDATION; MAJOR CLINICAL STUDY; MALE; OXIDATION KINETICS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SPECTROPHOTOMETRY; STATISTICAL SIGNIFICANCE; VASCULAR DISEASE;

AGED; ANTIBODIES; BIOLOGICAL MARKERS; CORONARY ARTERIOSCLEROSIS; FEMALE; HUMANS; LIPID PEROXIDATION; LIPOPROTEIN(A); LIPOPROTEINS; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 10644246973     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2004.09.011     Document Type: Article

References (39)

1. V. Fuster, and A. Lewis Conner memorial lecture. Mechanisms leading to myocardial infarction: insights from studies of vascular biology Circulation 90 1994 2126 2146
2. J.T. Willerson, P. Golino, J. Eidt, W.B. Campbell, and L.M. Buja Specific platelet mediators and unstable coronary artery lesions. Experimental evidence and potential clinical implications Circulation 80 1989 198 205
3. A. Fernandez-Ortiz, J.J. Badimon, and E. Falk Characterization of the relative thrombogenicity of atherosclerotic plaque components: implications for consequences of plaque rupture J. Am. Coll. Cardiol. 23 1994 1562 1569
4. Y. Nemerson Tissue factor and hemostasis Blood 71 1 1988 1 8
5. V. Fuster, J.T. Fallon, and Y. Nemerson Coronary thrombosis Lancet 348 1996 S7 S10
6. G.J. Broze Tissue factor pathway inhibitor Thromb. Haemost. 74 1995 S90 S93
7. G.J. Broze Tissue factor pathway inhibitor and the revised hypothesis of blood coagulation Trends Cardiovasc. Med. 2 1992 72 77
8. P.M. Sandset, U. Abildgoard, and M.L. Larsen Heparin induces release of extrinsic coagulation pathway inhibitor (EPI) Thromb. Res. 50 1988 803 813 [Suppl.]
9. A.R. Hubbard, and C.A. Jennings Inhibition of the tissue factor-factor VII complex: involvement of factor Xa and lipoproteins Thromb. Res. 46 1987 527 537 [Suppl.]
10. W.F. Novotny, T.J. Girard, J.P. Miletich, and G.J. Broze Jr. Platelets secrete a coagulation inhibitor functionally and antigenically similar to the lipoprotein associated coagulation inhibitor Blood 72 1988 2020 2025
11. J.B. Hansen, N.E. Huseby, P.M. Sandset, B. Svensson, V. Lyngmo, and A. Nordoy Tissue-factor pathway inhibitor and lipoproteins. Evidence for association with and regulation by LDL in human plasma Arterioscler. Thromb. 14 1994 223 229
12. J. Loscalzo, M. Weinfeld, G.M. Fless, and A.M. Scanu Lipoprotein (a), fibrin binding, and plasminogen activation Atherosclerosis 10 2 1990 240 245
13. P. Lesnik, C. Dentan, A. Vonica, M. Moreau, and M.J. Chapman Tissue factor pathway inhibitor activity associated with LDL is inactivated by cell- and copper-mediated oxidation Arterioscler. Thromb. Vasc. Biol. 15 1995 1121 1130
14. W.G. Austen, J.E. Edwards, and R.L. Frye A reporting system on patients evaluated for coronary artery disease: report of the ad hoc committee for grading of coronary artery disease, council on cardiovascular surgery, American Heart Association Circulation 51 1975 5 40
15. J.A. Buege, and S.D. Aust Microsomal lipid peroxidation Methods Enzymol. 12 1978 302 310
16. Microsoft Corporation. Microsoft Excel 5.0 Cambridge, MA, USA: Microsoft Corporation; 1994.
17. Stata Release 5.0. College Station, TX, USA: Stata Corporation; 1994.
18. H.K. Kim, K.S. Song, Y.S. Park, Y.S. Yun, and W.H. Shim Changes of plasma tissue factor and tissue factor pathway inhibitor antigen levels and induction of tissue factor expression on the monocytes in coronary artery disease Cardiology 93 2000 31 36
19. T. Lindhout, R. Blezer, P. Schben, O. Nordfang, C. Reutelingsperger, and H.C. Hemker Activation of factor X and its regulation by tissue factor pathway inhibitor in small-diameter capillaries lined with human endothelial cells Blood 79 1992 2909 2916
20. G.J. Broze Jr., L.A. Warren, W.F. Novotny, D.A. Higuchi, J.J. Girard, and J.P. Miletich The lipoprotein-associated coagulation inhibitor that inhibits the factor VII-tissue factor complex also inhibits factor Xa: insight into its possible mechanism of action Blood 71 1988 335 343
21. A.K. Lindahl, P.B. Jacobsen, P.M. Sandset, and U. Abildgaard Tissue factor pathway inhibitor with high anticoagulant activity is increased in post-heparin plasma and in plasma from cancer patients Blood Coagul. Fibrinolysis 2 1991 713 721
22. E.F. Grabowski, D.B. Zuckerman, and Y. Nemerson The functional expression of tissue factor by fibroblasts and endothelial cells under flow conditions Blood 81 1993 3265 3270
23. K.L. Chien, Y.T. Lee, F.C. Sung, T.C. Su, H.C. Hsu, and R.S. Lin Lipoprotein (a) level in the population in Taiwan: relationship to sociodemographic and atherosclerotic risk factors Atherosclerosis 143 1999 267 273
24. J.A. Berliner, and J.W. Heinecke The role of oxidized lipoproteins in atherogenesis Free Radic. Biol. Med. 20 1996 707 727
25. M.D. Coffey, R.A. Cole, S.M. Colles, and G.M. Chisolm In vitro cell injury by oxidized low density lipoprotein involves lipid hydroperoxide-induced formation of alkoxyl, lipid, and peroxyl radicals J. Clin. Invest. 96 1995 1866 1873
26. E. Camille, B.R. Wilbourn, J.M. Adam, N.J. James, and K.R. Bruchdurfer Comparison of the inhibitory effects of ApoB100 and tissue factor pathway inhibitor on tissue factor and the influence of lipoprotein oxidation Arterioscler. Thromb. Vasc. Biol. 19 1999 1784 1790
27. N.M. Caplice, C. Panetta, and T.E. Peterson Lipoprotein (a) binds and inactivates tissue factor pathway inhibitor: a novel link between lipoproteins and thrombosis Blood 98 10 2001 2980 2987
28. G.J. Broze Tissue factor pathway inhibitor Thromb. Haemost. 74 1995 90 93
29. M. Sandset Tissue factor pathway inhibitor (TFPI). An update Haemostasis 26 S4 1996 154 165
30. D. Zitoun, L. Bara, A. Basdevant, and M.M. Samama Levels of factor VIIc associated with decreased tissue factor pathway inhibitor and increased plasminogen activator inhibitor-1 in dyslipidemias Arterioscler. Thromb. Vasc. Biol. 16 1 1996 77 81
31. P. Lesnik, A. Vonica, M. Guerin, M. Moreau, and M.J. Chapman Anticoagulant activity of tissue factor pathway inhibitor in human plasma is preferentially associated with dense subspecies of LDL and HDL and with Lp(a) Arterioscler. Thromb. 13 1993 1066 1075
32. E. Moor, A. Hamsten, F. Karpe, P. Bavenholm, M. Blombäck, and A. Silveira Relationship of tissue factor pathway inhibitor activity to plasma lipoproteins and myocardial infarction at a young age Thromb. Haemost. 71 1994 707 712
33. V. Roldan, F. Marin, and P. Fernandez Tissue factor/tissue factor pathway inhibitor system and long-term prognosis after acute myocardial infarction Int. J. Cardiol. 78 2 2001 115 119
34. P. Holvoet, A. Mertens, and P. Verhamme Circulating oxidized LDL is a useful marker for identifying patients with coronary artery disease Arterioscler. Thromb. Vasc. Biol. 21 5 2001 844 848
35. K. Brand, C.L. Banka, N. Mackman, K.A. Terkeltaub, S.T. Fan, and L.K. Curtiss Oxidized LDL enhances lipopolysaccharide-induced tissue factor expression in human adherent monocytes Arterioscler. Thromb. 14 1994 790 797
36. T.A. Drake, K. Hannani, H.H. Fei, S. Lavi, and J.A. Berliner Minimally oxidized low-density lipoprotein induces tissue factor expression in cultured human endothelial cells Am. J. Pathol. 138 1991 601 607
37. R.A. Ariens, M. Moia, E. Rivolta, C. Ponticelli, and P.M. Mannucci High levels of tissue factor pathway inhibitor in patients with nephrotic proteinuria Thromb. Haemost. 82 1999 1020 1023
38. H.K. Kim, K.S. Song, Y.S. Park, Y.S. Yun, and W.H. Shim Changes of plasma tissue factor and tissue factor pathway inhibitor antigen levels and induction of tissue factor expression on the monocytes in coronary artery disease Cardiology 93 2000 31 36
39. B. Osterud, M.S. Bajaj, and S.P. Bajaj Sites of tissue factor pathway inhibitor (TFPI) and tissue factor expression under physiologic and pathologic conditions Thromb. Haemost. 73 1995 873 875